GERALD GAMBRILL: Open Payments
NPI 1982620019 · OTTAWA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 13 payments from 3 companies in 2025. Trend: 2023 $72 · 2024 $35 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 10 | $114 |
| Alkermes, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: Qelbree, ARISTADA, REXULTI.
Industry payments across KS — which companies pay providers there.
